Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 2, 2001, Pages 583-592

  Liu, Li ^a   Li, Han ^a   Underwood, Tashandra ^a   Lloyd, Marti ^a   David, Mary ^a   Sperl, Gerhard ^a   Pamukcu, Rifat ^a   Thompson, W Joseph ^a,b  

^a Cell Pathways Inc   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; BETA CATENIN; CP 461; CYCLIC GMP DEPENDENT PROTEIN KINASE; DNA FRAGMENT; GUANYLATE CYCLASE; GUANYLIN; PHOSPHODIESTERASE; SULINDAC SULFONE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING SITE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL CULTURE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CLONING, MOLECULAR; COLONIC NEOPLASMS; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYTOSKELETAL PROTEINS; DNA FRAGMENTATION; ENZYME ACTIVATORS; GASTROINTESTINAL HORMONES; HUMANS; MUTATION; NATRIURETIC PEPTIDES; PEPTIDES; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLATION; RADIOIMMUNOASSAY; SULINDAC; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0034757918     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype
2. Radioimmunoassay of cyclic AMP and cyclic GMP
3. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues
4. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP
5. Activation by autophosphorylation or cGMP binding produces a similar apparent conformational change in cGMP-dependent protein kinase
6. A phenylalanine in peptide substrates provides for selectivity between cGMP- and cAMP-dependent protein kinases
7. Purification and assay of cAMP, cGMP, and cyclic nucleotide analogs in cells treated with cyclic nucleotide analogs
8. Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells
9. The role of protein kinase G activation in cGMP-mediated apoptosis in human colon cancer cells
10. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells
11. Arginine 75 in the pseudosubstrate sequence of type Iβ cGMP-dependent protein kinase is critical for autoinhibition, although autophosphorylated serine 63 is outside this sequence
12. cGMP-dependent protein kinase. Autophosphorylation changes the characteristics of binding site 1
13. E-Cadherin and APC compete for the interaction with β-catenin and the cytoskeleton
14. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides
15. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells
16. Exisulind regulates PDE5/2 gene expression in SW480 human colon tumor cells
17. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15
18. The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone
19. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
20. Secretion of cyclic GMP by cultured epithelial and fibroblast cell lines in response to nitric oxide
21. Phosphodiesterase 5 overexpression in human non-small cell lung tumors compared to normal bronchial epithelium
22. Cyclic GMP phosphodiesterase (cG PDE) overexpression in human pancreatic carcinomas and a target for selective apoptotic antineoplastic drugs
23. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis
24. Overexpression of cGMP phosphodiesterase (cG PDE) in colonic neoplasias compared to normal mucosa
25. Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells
26. Assays of protein kinase
27. Evidence for the presence of cGMP-dependent protein kinase-II in human distal colon and in T84, the colonic cell line
28. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP
29. Isolation and expression of a guanylate cyclase-coupled heat stable enterotoxin receptor cDNA from a human colonic cell line
30. Autophosphorylation of type Iβ cGMP-dependent protein kinase increases basal catalytic activity and enhances allosteric activation by cGMP or cAMP
31. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase
32. Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1
33. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis
34. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism
35. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase
36. Exisulind induces apoptosis in colonic tumor cells lacking APC mutations by cyclic GMP mediated β-catenin reduction
37. Exisulind induction of apoptosis involves guanosine 3′,5′cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, attenuated beta-catenin
38. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes